Forbes June 24, 2020
Sally Pipes

This week, the House of Representatives is set to vote on legislation designed to “stabilize” Obamacare. Democrats claim the plan, which extends exchange subsidies to a broader share of the population, will help more Americans afford health insurance in the midst of the pandemic and accompanying economic crisis.

But the legislation would do nothing to address the root causes of Obamacare’s unaffordability. Worse still, it would fund these new subsidies by taking money from drug companies through a combination of price controls and taxes.

The world desperately needs effective vaccines and treatments for Covid-19. And Democrats want to raid the coffers of the companies investing in that research, in order to line the pockets of insurance companies? That makes no...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ACA (Affordable Care Act), Congress / White House, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Payer, Provider, Public Exchange, Public Health / COVID, Regulations
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
Gene Therapy Shows Long-Term Vision Benefits in Rare Eye Disease
PBM reform dropped in Congress' funding package
Trump's Picks for Top Health Jobs Not Just Team of Rivals but 'Team of Opponents'
Happy Holidays: Is Your Doctor Happy? Are You Happy With Your Doctor?

Share This Article